Unknown PHASE1 INTERVENTIONAL 1-arm NCT01033214

ENTRUST - TAArget® Thoracic Stent Graft Clinical Trial

A Phase I Feasibility Study of the TAArget Thoracic Stent Graft for the Treatment of Aneurysms in the Descending Thoracic Aorta

Sponsor: Duke Vascular, Inc.

Conditions Thoracic Aortic Aneurysm

Interventions Endovascular repair of TAA in the descending Thoracic Aorta

Updated 7 times since 2017 Last updated: May 18, 2015 Started: Jan 31, 2010 Primary completion: Jun 30, 2011 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01033214, this PHASE1 trial focuses on Thoracic Aortic Aneurysm and remains ongoing. Sponsored by Duke Vascular, Inc., it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jun 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Jun 2017 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke Vascular, Inc.

Data source: Duke Vascular, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States
• Newark, United States